Aether Bio

Aether Bio

Private
Menlo Park, CaliforniaFrontier & Industrial Techhttps://www.aetherbio.com

Last Round

Series A

Dec 3, 2025

Total Funding Raised

$75.5M

Momentum Score

50 /100

Company Overview

Aether (Discovery Tools) is a biotechnology company that specializes in machine learning technology to engineer enzymes for the rapid creation of new compounds.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, Advanced Materials, Clean Manufacturing, Drug Discovery, Carbon Capture

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Infrastructure

Keywords

enzyme engineeringbiocatalyst designsynthetic biologysynbiocustom enzymesprotein engineeringenzyme discoverybio foundrylab automationmachine learningPFAS degradationhigh-throughput screeningbiomanufacturingmineral extractionlithium extractionadvanced materials synthesisdrug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aether Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Aether Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series ADec 3, 2025
Series AAug 16, 2023
SeedDec 1, 2020

Key People

Founding team and executive leadership

Pavle Jeremić

CEO Founder

Founding Team

Aether Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 4, 2025

    Jay Zaveri joins as the new president.

  • Dec 3, 2025

    $15M round raised

Aether Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Aether Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aether Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersMenlo Park, California
Employee Range80
Year Founded2017
Last FundingDec 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.